pegylated recombinant human granulocyte-colony stimulating factor

DRUG2 trials

Sponsors

Sun Yat-sen University, Yao Liu

Conditions

LymphomaMultiple MyelomaPediatric Cancer

Phase 2

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

Sun Yat-sen UniversityPediatric Cancer

Start: 2020-10-10End: 2023-05-10Target: 108Updated: 2021-09-02

Unknown Phase

Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma

Yao LiuLymphoma, Multiple Myeloma

Start: 2022-04-22End: 2024-04-30Target: 7Updated: 2023-09-29

Related Papers

A multicenter phase <scp>II</scp> trial of primary prophylactic <scp>PEG‐rhG‐CSF</scp> in pediatric patients with solid tumors and <scp>non‐Hodgkin</scp> lymphoma after chemotherapy: An interim analysis

Cancer Medicine2023-05-154 citations